NCT00229476
Completed
Phase 4
Study of Medication and Placebo Response in Major Depression
ConditionsDepressive Disorder, Major
Drugssertraline (Zoloft)
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Depressive Disorder, Major
- Sponsor
- University of California, Los Angeles
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- depressive symptoms
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The primary purpose of the research study is to use recordings of brain electrical activity (through electroencephalogram, or EEG) and symptom measurements to determine whether patients are likely to show a response to medication or placebo treatment during a treatment trial for depression.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Clinical Diagnosis of Unipolar Major Depression
Exclusion Criteria
- •Substance Abuse, Psychotic Disorder, History of Severe Head Trauma
Outcomes
Primary Outcomes
depressive symptoms
Secondary Outcomes
- brain electrical activity (EEG)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Early Phase 1
Neurophysiological and Acute Pharmacological Studies in FXS PatientsFragile X SyndromeNCT02998151Children's Hospital Medical Center, Cincinnati29
Completed
Phase 1
A Study To Assess Effects Of PF-04958242 On Bold Functional Magnetic Resonance Imaging During Working Memory Activation And Arterial Spin Labeling At Rest In Healthy SubjectsHealthy VolunteerNCT01365338Biogen112
Completed
Phase 4
Treatment of Depression Following Multiple Brain TestsMajor DepressionDysthymiaNCT00296777New York State Psychiatric Institute28
Completed
Phase 4
Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity DisorderAttention Deficit-Hyperactivity DisorderNCT01831622Mats Fredriksen131
Completed
Not Applicable
Attention-Deficit/Hyperactivity Disorder (ADHD) Brain Activity Changes to PsychostimulantsAttention Deficit Hyperactivity DisorderNCT01310439Hartford Hospital38